@Tommy_Conlin@alc2022 More coverage by investors. Less time now until units sold and results back. More stock volume trading. Thesis intact, just plan B, until they can unlock more of the human proteome.
This poem is so bad that writing it should have disqualified its author from any Nobel Prize, in any category, ever.
And, why isn’t UFO Twitter all over this? It’s fairly clear evidence that Vogons came to earth in 2001 and infiltrated The New Yorker.
Too annoying to follow posts like this. Just get to the data points already. I don't need bait to click on.
Grok says:
Life Biosciences (David Sinclair’s company) is presenting the first interim human data on ER-100 this week at Eyecelerator in New Orleans, October 8. ER-100 is a gene therapy that briefly turns on three Yamanaka factors — OCT4, SOX2, and KLF4 — to reset epigenetic marks toward a younger pattern without turning cells into stem cells. The Phase 1 is in people with glaucoma and other optic-nerve damage, not healthy aging. Endpoints are safety and visual function. First patient was dosed around June 2026.
"Studies found that women had around 45% higher blood concentrations of ambien (zolpidem) than men after the same dose. Women also cleared the drug from the bloodstream more slowly."
@talmagejohnson_ Don't need luck for that.
Rejection is easy and common.
Might as well enjoy it. That's what I'll wish you: Enjoy the rejection. Then you can't lose.
I suppose I should ask an AI. Feed it all my data, let it watch me and know everything about me and have it give me a top 10 career list to choose from based on the data.
Let's all just give our lives over to the super human intelligence algorithms to optimize for efficiency and fulfillment.....? But then what about our emotional need for autonomy and developing a personal identity. Looked at the psychology of youth, teenage years. The identity development that seems hardwired into us to find. Seems like it all comes down to emotion. The AI will eventually make the best decisions for us, but how can we do it in a way where we feel right about following the AI's advice?
Should that even be the question? Am I down a non-ideal train of thought?
I would choose being the best biotechnology longevity CEO on the planet. Like the Elon Musk of longevity biotechnology.
Why? I feel like it has the greatest meaning for the greatest number of people, to solve the problem of death 💀 increase health-span until we solve death.
That said, what good is that question when:
We ultimately can only do what we're really interested/motivated/emotionally driven (optimally fulfilled doing) to do?
Wouldn't a better question be:
How can I discover what thing(s) I am optimally emotionally driven to do? What activities will give me the most meaning/dopamine/fulfillment over a lifetime.
Perhaps the answer to your question is that I would choose to be the best at figuring out what any person is best interested/motivated/emotionally driven to do (in terms of a career?) then I would figure out what would give me the most fulfillment. Then again, isn't that a dynamic thing?
Acting would have been a good fit for me, but I had serious doubts about making enough money. Being a singer would have been fun too, for a while, but I couldn't see myself singing and performing for decades.
Isn't the answer somewhat dependant on ones cognitive nature?
What is your cognitive nature/ability + your interests + what the world needs/pays for + (variables xyz)?
How does one even figure this shit out!??
What happened to me is bigger than one artist or one stage. When the billionaire class can decide which voices are allowed on stage and which ones are too dangerous to hear, everyone should be paying attention.
So we're going on tour. All proceeds will benefit organizations supporting the Palestinian people and movement.
Sign up at https://t.co/2na35y8pQ5
I've focused for 25 years on aging damage repair, many of them while it was viewed as unscientific. Not any more! In December I oversee the Friday program at the Trampoline Zermatt Summit, with about 100 founders, investors and scientists. 2-6 December, by invitation.